Washington, D.C. (PRWEB) February 05, 2018
Global law firm Greenberg Traurig, LLP is a sponsor of the Clinical Innovation conference “Fair and Effective Incentives for New Uses of Established Drugs,” Feb. 8-9, at Georgetown Law Center in Washington, D.C.
There is increasing evidence that established medications can be used for the treatment of more than one illness. However, many pharmaceutical companies don’t want to spend the time and money required for secondary medical research and testing. This conference will discuss how many opportunities for secondary medical uses of established drugs are being ignored and what can be done to incentivize research into new uses of these known medicines.
Shareholder Nancy E. Taylor will moderate a session about "The Payor's Perspective: Regulating to incentivize value creation and repair a failed market." Additionally, Shareholder Barry J. Schindler will be a panelist during the conference, speaking on "Plausibility and Second Medical Use Patents."
For more information or to see the full agenda, please visit the conference website.
About Greenberg Traurig’s Health Care & FDA Practice
Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.
About Greenberg Traurig’s Intellectual Property & Technology Practice
Greenberg Traurig’s Intellectual Property & Technology practice has more than 200 intellectual property attorneys and agents in the United States, Asia, and Europe, providing a broad range of patent, trademark and copyright protection and strategic counseling. Greenberg Traurig was named a “National Tier 1” Law Firm for IP Litigation, Patent Law, Trademark and Information Technology Law by U.S. News and Best Lawyers, 2017 “Best Law Firms Rankings.”
About Greenberg Traurig
Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2017 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.